Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics

by Laura Molenaar‐Kuijsten, Bart Albertus Wilhelmus Jacobs, Sophie Alberdine Kurk, Anne Maria May, Thomas Petrus Catharina Dorlo, Jacob Hendrik Beijnen, Neeltje Steeghs, Alwin Dagmar Redmar Huitema
Published 2021-07-01

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs

by Laura Molenaar-Kuijsten, Dorieke E. M. Van Balen, Jos H. Beijnen, Jos H. Beijnen, Neeltje Steeghs, Alwin D. R. Huitema, Alwin D. R. Huitema, Alwin D. R. Huitema
Published 2021-08-01